Results 21 to 30 of about 27,203 (237)

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

To Evaluate the Effectiveness of Plasmapheresis as a Method for the Graft Disease Prevention in Patients with Keratoplasty

open access: yesOftalʹmologiâ, 2021
Purpose: to evaluate the effectiveness of plasmapheresis as a method for preventing and treating the graft rejection reaction in corneal transplantation.Patients and methods.
S. N. Sakhnov   +3 more
doaj   +1 more source

Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

open access: yesEuropean Journal of Neurology, Volume 30, Issue 1, Page 266-282, January 2023., 2023
Myasthenia gravis is recognized as an immunoglobulin G autoantibody‐mediated disease, but the relationship between autoantibody levels and disease activity is unclear. We conducted a systematic literature review to evaluate this landscape, which yielded 10 studies mainly describing a positive, significant correlation.
Andreas Meisel   +13 more
wiley   +1 more source

Peran Plasmafaresis pada Terapi Pasien Sepsis dengan Myasthenia Gravis

open access: yesJAI (Jurnal Anestesiologi Indonesia), 2013
Pendahuluan : Plasmapheresis berpotensi untuk menghilangkan mediator berbahaya atau beracun dari sirkulasi . Plasmapheresis telah menunjukkan peningkatan keluaran yang bermakna pada penyakit autoimun .
Ahmad Imron   +2 more
doaj   +1 more source

Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study

open access: yesEuropean Journal of Neurology, Volume 30, Issue 2, Page 463-473, February 2023., 2023
In this study we define long‐term characteristics of various neurological autoimmune disorders encountered after SARS‐CoV‐2 vaccinations. Long‐term outcome was favorable in most cases. Re‐vaccinations were well‐tolerated and should be considered on an individual risk/benefit analysis.
Sofia Doubrovinskaia   +11 more
wiley   +1 more source

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients

open access: yesKorean Journal of Transplantation, 2020
The role of the isoagglutinin (IA) titer in liver transplantation (LT) is still not well defined, but the general belief is that a higher titer may result in a higher risk of rejection in ABO-incompatible living donor LT.
Boram Lee   +5 more
doaj   +1 more source

Plasmapheresis in Acute Fatty Liver of Pregnancy: An Effective Treatment

open access: yesCase Reports in Obstetrics and Gynecology, 2013
Acute fatty liver of pregnancy (AFLP) is an idiopathic disorder with an unknown cause occurring in late pregnancy. The treatment in these patients is often immediate termination of pregnancy, and plasmapheresis provides an effective treatment option.
Mohammad Reza Seyyed Majidi   +1 more
doaj   +1 more source

Plasmapheresis in the treatment of hypertriglyceridemia [PDF]

open access: yesOrvosi Hetilap, 2014
The authors present the case of a 38-year-old woman with severe hypertriglyceridemia-induced acute recurrent pancreatitis (triglyceride 16 761 mg/dl, 189.4 mmol/l). According to the knowledge of the authors, such a high triglyceride has not been previously reported in Hungarian and international scientific literature.
Eldin_Mohamed Gamal   +6 more
openaire   +3 more sources

Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis

open access: yesCase Reports in Hematology, 2018
Background. Spur cell anemia (SCA) is a cause of hemolytic anemia in patients with alcoholic liver cirrhosis. Because dyslipidemia is related to the development of spur cells, SCA was previously treated with plasmapheresis. Case Report.
Kenji Miki   +2 more
doaj   +1 more source

Reducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis

open access: yesAsian Journal of Transfusion Science, 2016
Background: Guillain–Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis.
Rekha Ramaswamy Iyer   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy